Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade

This case series study assesses the prevalence of microsatellite instability–high or mismatch repair–deficient prostate cancer and the clinical benefit of immune checkpoint blockade with anti–PD-1/PD-L1 therapy in this molecularly defined population.

http://bit.ly/2QVnx8I